Putnam Biorevolution ETFSYNBETF
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$31.20avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Putnam Biorevolution ETF (SYNB) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Franklin Resources Inc. ($3.9M), Royal Bank of Canada ($31K) and UBS Group AG ($374).
- Company
- Putnam Biorevolution ETF
- CUSIP
- 746729805
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 329 shares sold, net −329 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Franklin Resources Inc. | 0.00% | No change | 125,000 | $3.9M |
| Royal Bank of Canada | 0.00% | Reduce -25.0% | 989 | $31K |
| UBS Group AG | 0.00% | No change | 12 | $374 |
"% of holder's portfolio" is SYNB's weight in each manager's 13F, not the share of Putnam Biorevolution ETF the manager owns.